Mayo Clinic has the nation's largest integrated transplant center in the United States. This video showcases seamless collaboration across its three campuses, bringing together physicians from various specialties. They work to care for all patients, with particular focus on those with serious and complex care needs.
Through leading clinical programs, pioneering research and innovation, Mayo Clinic advances transplant medicine. We deliver exceptional outcomes, strong transplant rates, and personalized care tailored to each patient's unique needs. We also collaborate with referring clinicians to ensure continuity of care close to home.
Our vision is no patient should die while waiting for an organ transplant. We are investing in the clinical practice. We're investing in research and innovation. So as the patient comes here we can promise them we'll take care of them and we will not stop short of any treatment. That will help them to regain their life back. Across our 3 campuses, we actually have specialty care and transplantation, and combined our 3 centers are by far and away the largest transplant practice in the United States and certainly one of the largest transplant practices in the world. We do heart transplants, lung transplants, kidney transplants, liver transplants, and each of those organ groups get together several times a month. They develop common patient protocols, so any patient that comes to Mayo Clinic, regardless of the size, they get the same treatment. Many patients come to us and they're referred by their own local physicians. We are dedicated to making sure that we are working closely with the home team, so it's not that they're just handing the patient over and we know what's best and we're going to take over. We know. That it has to be a team going forward. It's very important to have that clear communication with the local physicians so then they understand what that patient went through and then how they could reach out to us if there's any issue that arises down the line. We are really good at delivering care to all patients, but especially those who are serious and complex situations. We do have a very strong experience with multi-organ transplant, not just, say, for example, a common type of transplant, which might be a liver with a kidney or a kidney with. Pancreas, but complicated things like heart and lung together or liver and heart together. In the last several years, machine perfusion of organs outside of the body has become very prominent. This gives us an opportunity to assess the organ for several hours on the machine. And then try to make it work for us. How do we make that organ better while we have a full control of that organ on the machine? We can make more organs available or treat the organs while they're on the machine so that they're less immunogenic. 13 patients die every day who are on a transplant list before they are able to reach the point of getting a transplant. We're trying to reverse that. And the way to reverse that is to create new organs, what we call de novo organs, and our research in that field targeting 3D organ printing, as well as the utilization of xenotransplantation, or what we call transplantation from organs that are coming from a genetically modified animal like the pig. AI. has been a game changer. We're, I would say, in the early adopter club in terms of applying AI to our practice. One of the most important uses of AI that we are working on now is the appropriate match of the donor and the recipient. We would like to make that match in a way that will allow this new organ to survive in the recipient for. With the least amount of complication guaranteeing them the best outcome. We do a transplant because we want to return them to full health, keeping them going for as long as can be possible with that new organ so that they really are back and full function. If you are looking to help your patient, we allow them faster access to transplant while maintaining some of the best outcomes in the nation. That combination of two diarrheals is the perfect formula for any patient with end organ failure needing transplantation.
